https://sentinelinitiative.org/news-events/publications-presentations/antipsychotic-medication-use-among-hospitalized-infants-0 |
Antipsychotic Medication Use Among Hospitalized Infants Using Inpatient Data in FDA’s Sentinel System |
Publications and Presentations |
11/17/2020 |
Publications and Presentations
11/17/2020 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/ustekinumab-dispensing-patterns-descriptive-analysis |
Ustekinumab Dispensing Patterns: A Descriptive Analysis |
Analyses |
11/24/2020 |
Analyses
11/24/2020 |
https://sentinelinitiative.org/methods-data-tools/sentinel-national-resource/patient-characteristics-and-utilization-patterns |
Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product |
|
01/30/2021 |
01/30/2021 |
https://sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation |
COVID-19 Pregnancy Study Implementation |
Methods, Data, & Tools |
02/24/2021 |
Methods, Data, & Tools
02/24/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/pregnancy-among-women-heart-failure-descriptive-analysis |
Pregnancy among Women with Heart Failure: A Descriptive Analysis |
Modular Programs |
03/07/2021 |
Modular Programs
03/07/2021 |
https://sentinelinitiative.org/methods-data-tools/sentinel-national-resource/identifying-prescribing-cascades-alzheimers-disease |
Identifying Prescribing Cascades in Alzheimer's Disease and Related Dementias: The Calcium Channel Blocker-Diuretic Prescribing Cascade |
|
03/14/2021 |
03/14/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/lymphoma-risk-following-guselkumab-risankizumab-or |
Lymphoma Risk following Guselkumab, Risankizumab, or Tildrakizumab Use: A Descriptive Analysis |
Modular Programs |
03/30/2021 |
Modular Programs
03/30/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2016 |
Duration of Follow Up for New Molecular Entities Approved in 2016 |
Analyses |
04/16/2021 |
Analyses
04/16/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2014-and |
Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015 |
Analyses |
04/16/2021 |
Analyses
04/16/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2010-2012 |
Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013 |
Analyses |
04/16/2021 |
Analyses
04/16/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2008-and |
Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009 |
Analyses |
04/16/2021 |
Analyses
04/16/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2005-2006 |
Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007 |
Analyses |
04/16/2021 |
Analyses
04/16/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2011 |
Duration of Follow Up for New Molecular Entities Approved in 2011 |
Analyses |
04/16/2021 |
Analyses
04/16/2021 |
https://sentinelinitiative.org/news-events/publications-presentations/utilization-hydroxyprogesterone-caproate-among-pregnancies |
Utilization of Hydroxyprogesterone Caproate among Pregnancies with Live Birth Deliveries in the Sentinel Distributed Database |
Publications and Presentations |
04/29/2021 |
Publications and Presentations
04/29/2021 |
https://sentinelinitiative.org/methods-data-tools/methods/treescan-pregnancy |
TreeScan in Pregnancy |
Methods, Data, & Tools |
07/14/2021 |
Methods, Data, & Tools
07/14/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017 |
Duration of Follow Up for New Molecular Entities Approved in 2017: A Descriptive Analysis |
Analyses |
08/13/2021 |
Analyses
08/13/2021 |
https://sentinelinitiative.org/methods-data-tools/sentinel-national-resource/bbcic-research-network-analysis-first-cycle |
BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated with High Neutropenia Risk Chemotherapy |
|
08/16/2021 |
08/16/2021 |
https://sentinelinitiative.org/methods-data-tools/methods/develop-common-protocol-data-quality-metrics-electronic-health-records |
Develop a Common Protocol for Data Quality Metrics in Electronic Health Records |
Methods, Data, & Tools |
08/18/2021 |
Methods, Data, & Tools
08/18/2021 |
https://sentinelinitiative.org/news-events/publications-presentations/use-mobile-app-capture-supplemental-health-information-0 |
Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical Research |
Publications and Presentations |
08/23/2021 |
Publications and Presentations
08/23/2021 |
https://sentinelinitiative.org/news-events/publications-presentations/comparing-outcomes-trial-eligible-vs-real-world-covid-19 |
Comparing Outcomes in Trial-Eligible vs Real-World COVID-19 Patients: The Case of Invasive Mechanical Ventilation |
Publications and Presentations |
08/23/2021 |
Publications and Presentations
08/23/2021 |
https://sentinelinitiative.org/news-events/publications-presentations/outpatient-identified-covid-19-and-subsequent-hospitalized |
Outpatient-Identified COVID-19 and Subsequent Hospitalized Thrombotic Events |
Publications and Presentations |
08/23/2021 |
Publications and Presentations
08/23/2021 |
https://sentinelinitiative.org/news-events/publications-presentations/strategies-use-real-world-data-conduct-covid-19-related |
Strategies for the Use of Real-World Data to Conduct COVID-19-Related Pharmacoepidemiology |
Publications and Presentations |
08/25/2021 |
Publications and Presentations
08/25/2021 |
https://sentinelinitiative.org/methods-data-tools/software-packages-toolkits/making-medicaid-data-more-accessible-through-common |
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs |
Methods, Data, & Tools |
09/24/2021 |
Methods, Data, & Tools
09/24/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-multiple-sclerosis-drugs-among-pregnant-women-live-birth |
Use of Multiple Sclerosis Drugs Among Pregnant Women with Live-Birth Deliveries: A Descriptive Analysis |
Assessments |
10/20/2021 |
Assessments
10/20/2021 |
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-community-building-and-outreach-center |
2022 Sentinel Community Building and Outreach Center Webinar Series |
Sentinel Initiative Events |
11/23/2021 |
Sentinel Initiative Events
11/23/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-and-hospitalized-depression-following |
Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis |
Analyses |
12/15/2021 |
Analyses
12/15/2021 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-and-hospitalized-depression-0 |
Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (A Follow-up to a Previous Analysis) |
Analyses |
12/15/2021 |
Analyses
12/15/2021 |
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-innovation-and-methods-seminar-series |
2022 Sentinel Innovation and Methods Seminar Series |
Sentinel Initiative Events |
01/01/2022 |
Sentinel Initiative Events
01/01/2022 |
https://sentinelinitiative.org/studies/drugs/zoloft-sertraline-0 |
Zoloft (Sertraline) & Intentional Self-Harm and Hospitalized Depression |
Studies |
01/04/2022 |
Studies
01/04/2022 |
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/thromboembolic-stroke-algorithm-defined-1 |
Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" |
Methods, Data, & Tools |
01/06/2022 |
Methods, Data, & Tools
01/06/2022 |
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gastrointestinal-bleeding-algorithm-defined-0 |
Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" |
Methods, Data, & Tools |
01/06/2022 |
Methods, Data, & Tools
01/06/2022 |
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/major-extracranial-bleeding-algorithm-defined-1 |
Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" |
Methods, Data, & Tools |
01/06/2022 |
Methods, Data, & Tools
01/06/2022 |
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intracranial-hemorrhage-algorithm-defined-1 |
Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis" |
Methods, Data, & Tools |
01/06/2022 |
Methods, Data, & Tools
01/06/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017-updated |
Duration of Follow Up for New Molecular Entities Approved in 2017: An Updated Descriptive Analysis |
Analyses |
01/21/2022 |
Analyses
01/21/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2019 |
Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis |
Analyses |
01/26/2022 |
Analyses
01/26/2022 |
https://sentinelinitiative.org/news-events/publications-presentations/evaluating-confounding-control-estimations-influenza-0 |
Evaluating Confounding Control in Estimations of Influenza Antiviral Effectiveness in Electronic Health Plan Data |
Publications and Presentations |
02/02/2022 |
Publications and Presentations
02/02/2022 |
https://sentinelinitiative.org/studies/drugs/prenatal-tests |
Prenatal Tests & Stillbirth |
Studies |
02/03/2022 |
Studies
02/03/2022 |
https://sentinelinitiative.org/news-events/publications-presentations/utility-fertility-procedures-and-prenatal-tests-estimate-0 |
Utility of Fertility Procedures and Prenatal Tests to Estimate Gestational Age for Live-births and Stillbirths in Electronic Health Plan Databases |
Publications and Presentations |
02/05/2022 |
Publications and Presentations
02/05/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/n-nitrosodimethylamine-ndma-contaminated-and-non-ndma |
N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis |
Analyses |
02/18/2022 |
Analyses
02/18/2022 |
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/do-all-roads-lead-fhir-imagining-fhir-meta-common-data |
Do All Roads Lead to FHIR? Imagining FHIR as a Meta-Common Data Model for Research |
Sentinel Initiative Events |
02/24/2022 |
Sentinel Initiative Events
02/24/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/tofacitinib-disease-modifying-anti-rheumatic-drugs-dmards |
Tofacitinib, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) and Tumor Necrosis Factor Inhibitors (TNFi) Use: A Descriptive Analysis |
Analyses |
02/24/2022 |
Analyses
02/24/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/bleeding-events-and-venous-thromboembolism-vte-following |
Bleeding Events and Venous Thromboembolism (VTE) following Enoxaparin Use: A Descriptive Analysis |
Analyses |
02/25/2022 |
Analyses
02/25/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-n-nitrosodimethylamine-ndma-and-n |
Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis |
Analyses |
03/01/2022 |
Analyses
03/01/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/mometasone-furoate-mf-sinus-implant-use-patients-nasal |
Mometasone Furoate (MF) Sinus Implant Use in Patients with Nasal Polyps: A Descriptive Analysis |
Analyses |
03/03/2022 |
Analyses
03/03/2022 |
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/vyvgart-efgartigimod-alfa-fcab |
Assessment of ARIA Sufficiency: Vyvgart (efgartigimod alfa-fcab) |
Sufficiency Assessments |
03/08/2022 |
Sufficiency Assessments
03/08/2022 |
https://sentinelinitiative.org/methods-data-tools/methods/improving-capture-race-and-ethnicity-data-sentinel |
Improving Capture of Race and Ethnicity Data in Sentinel |
Methods, Data, & Tools |
03/08/2022 |
Methods, Data, & Tools
03/08/2022 |
https://sentinelinitiative.org/news-events/publications-presentations/cnodes-webinar-surveillance-adverse-infant-outcomes |
CNODES Webinar: Surveillance of Adverse Infant Outcomes Following Maternal Medication Use During Pregnancy Using Tree-Based Scan Statistics |
Publications and Presentations |
03/09/2022 |
Publications and Presentations
03/09/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/human-epidermal-growth-factor-receptor-2-her2-antagonist-use |
Human Epidermal Growth Factor Receptor 2 (HER2) Antagonist Use in Patients with Live Birth Deliveries: A Descriptive Analysis |
Analyses |
03/11/2022 |
Analyses
03/11/2022 |
https://sentinelinitiative.org/methods-data-tools/methods/sentinel-innovation-center-request-proposal-feature-engineering |
Sentinel Innovation Center Request for Proposal: Feature Engineering |
Methods, Data, & Tools |
03/15/2022 |
Methods, Data, & Tools
03/15/2022 |
https://sentinelinitiative.org/methods-data-tools/methods/augmenting-date-death-cause-death-ascertainment-sentinel |
Augmenting Date of Death & Cause of Death Ascertainment in Sentinel |
Methods, Data, & Tools |
03/16/2022 |
Methods, Data, & Tools
03/16/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incident-and-prevalent-use-loop-diuretics-descriptive |
Incident and Prevalent Use of Loop Diuretics: A Descriptive Analysis |
Analyses |
03/23/2022 |
Analyses
03/23/2022 |
https://sentinelinitiative.org/engage-sentinel/quarterly-newsletter |
Quarterly Newsletter |
Spotlight |
03/24/2022 |
Spotlight
03/24/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/valganciclovir-use-children-congenital-cytomegalovirus |
Valganciclovir Use in Children with Congenital Cytomegalovirus Disease (cCMV) or Cytomegalovirus (CMV) Infection: A Descriptive Analysis |
Analyses |
03/25/2022 |
Analyses
03/25/2022 |
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/data-leakage-due-care-provided-outside-study-electronic |
Data Leakage Due to Care Provided Outside of the Study Electronic Health Record System: Potential Biases and Solutions |
Sentinel Initiative Events |
03/28/2022 |
Sentinel Initiative Events
03/28/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/epidiolex-prescription-cannabidiol-utilization-patterns |
Epidiolex (prescription cannabidiol) Utilization Patterns: A Query Builder Analysis |
Analyses |
03/28/2022 |
Analyses
03/28/2022 |
https://sentinelinitiative.org/news-events/publications-presentations/landscape-analysis-valganciclovir-treatment-congenital |
A Landscape Analysis of Valganciclovir Treatment for Congenital Cytomegalovirus Infection in the United States (US), 2008-2021 |
Publications and Presentations |
03/28/2022 |
Publications and Presentations
03/28/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/hydroxyurea-use-among-patients-sickle-cell-disease-scd |
Hydroxyurea Use Among Patients with Sickle Cell Disease (SCD): A Descriptive Analysis |
Analyses |
03/29/2022 |
Analyses
03/29/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/estimated-prevalence-glomerular-diseases-descriptive |
Estimated Prevalence of Glomerular Diseases: A Descriptive Analysis |
Analyses |
03/29/2022 |
Analyses
03/29/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/estimated-prevalence-glomerular-diseases-updated-descriptive |
Estimated Prevalence of Glomerular Diseases: An Updated Descriptive Analysis |
Analyses |
03/29/2022 |
Analyses
03/29/2022 |
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/saphnelo-anifrolumab-fnia |
Assessment of ARIA Sufficiency: Saphnelo (anifrolumab fnia) |
Sufficiency Assessments |
04/01/2022 |
Sufficiency Assessments
04/01/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-brodalumab-descriptive-analysis |
Utilization of Brodalumab: A Descriptive Analysis |
Analyses |
04/05/2022 |
Analyses
04/05/2022 |
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system |
Sentinel Routine Querying System |
Methods, Data, & Tools |
04/05/2022 |
Methods, Data, & Tools
04/05/2022 |
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool |
Sentinel Routine Querying System Reporting Tool |
Methods, Data, & Tools |
04/05/2022 |
Methods, Data, & Tools
04/05/2022 |
https://sentinelinitiative.org/news-events/publications-presentations/systemic-corticosteroid-use-covid-19-us-outpatient-settings |
Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021 |
Publications and Presentations |
04/08/2022 |
Publications and Presentations
04/08/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-individuals-drug-device |
Counts and Characteristics of Individuals With Drug-Device Combination Use: A Descriptive Analysis |
Analyses |
04/18/2022 |
Analyses
04/18/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2018 |
Duration of Follow Up for New Molecular Entities Approved in 2018: A Descriptive Analysis |
Analyses |
04/20/2022 |
Analyses
04/20/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-confounding-variables-over-time |
Incidence and Prevalence of Confounding Variables Over Time in the Sentinel Distributed Database (SDD): A Descriptive Analysis |
Analyses |
04/21/2022 |
Analyses
04/21/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/thromboembolic-stroke-major-extracranial-bleeding-0 |
Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis |
Analyses |
04/25/2022 |
Analyses
04/25/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/death-data-exploration-descriptive-analysis |
Death Data Exploration: A Descriptive Analysis |
Analyses |
04/28/2022 |
Analyses
04/28/2022 |
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-innovation-day-sentinel-public-training-april-28-29 |
2022 Innovation Day & Sentinel Public Training, April 28 - 29 |
Sentinel Initiative Events |
04/28/2022 |
Sentinel Initiative Events
04/28/2022 |
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-innovation-day |
2022 Sentinel Innovation Day |
Sentinel Initiative Events |
04/28/2022 |
Sentinel Initiative Events
04/28/2022 |
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-public-training-day |
2022 Sentinel Public Training Day |
Sentinel Initiative Events |
04/29/2022 |
Sentinel Initiative Events
04/29/2022 |
https://sentinelinitiative.org/news-events/publications-presentations/use-real-world-data-surveillance-medications-pregnancy |
Use of Real-World Data for Surveillance of Medications in Pregnancy |
Publications and Presentations |
05/09/2022 |
Publications and Presentations
05/09/2022 |
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/can-we-train-machine-learning-methods-outperform-high |
Can We Train Machine Learning Methods to Outperform the High-Dimensional Propensity Score Algorithm? |
Sentinel Initiative Events |
05/11/2022 |
Sentinel Initiative Events
05/11/2022 |
https://sentinelinitiative.org/studies/drugs/aldactone-spironolactone |
Aldactone (spironolactone) & Indications for Use |
Studies |
05/16/2022 |
Studies
05/16/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-pediatric-demographics-and-enrollment |
Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: A Descriptive Analysis |
Analyses |
05/16/2022 |
Analyses
05/16/2022 |
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/serious-infection-following-ustekinumab-use-patients-crohn-s |
Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease or Ulcerative Colitis: A Descriptive Analysis |
Analyses |
05/17/2022 |
Analyses
05/17/2022 |